EvoNext Holdings SA (SWX:EVE)
Switzerland · Delayed Price · Currency is CHF 0.9840
-0.1160 (-10.55%)
Aug 14, 2025, 5:31 PM CET
EvoNext Holdings Company Description
EvoNext Holdings SA is in the process of liquidation of its remaining assets.
Previously, the company was engaged in discovery, research, development, and commercialization of nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally.
The company was formerly known as Evolva Holding SA and changed its name to EvoNext Holdings SA in July 2025.
The company was incorporated in 2001 and is headquartered in Reinach, Switzerland.
EvoNext Holdings SA
| Country | Switzerland |
| Founded | 2001 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 78 |
Contact Details
Address: Duggingerstrasse 23 Reinach, 4153 Switzerland | |
| Phone | 41 61 485 2000 |
| Website | evolva.com |
Stock Details
| Ticker Symbol | EVE |
| Exchange | SIX Swiss Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CHF |
| ISIN Number | CH0021218067 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Gerhard Lobmaier | Chief Operations Officer |
| Thomas Schneckenburger C.F.A., Ph.D. | Head of Investor and Corporate Relations |
| Anne De Vos | Head of Sales |
| Astrid Schafer | Head of Innovation |
| Dr. Luc Gruner | Executive Officer |